• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺微小乳头状癌超声表现与BRAF V600E突变的相关性

Correlation between Ultrasonographic Appearance of Papillary Thyroid Microcarcinoma and BRAF V600E Mutation.

作者信息

Liang Songnian, Huang Kun

机构信息

Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

Department of Ultrasonic Diagnosis, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

出版信息

J Oncol. 2022 Mar 21;2022:5916379. doi: 10.1155/2022/5916379. eCollection 2022.

DOI:10.1155/2022/5916379
PMID:35356255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959952/
Abstract

The study was conducted to investigate the correlation between the ultrasonographic appearance of a thyroid nodule and the BRAF V600E mutation. Patients with thyroid nodules ( = 186), for which BRAF V600E testing and cytopathology analysis were performed, and who underwent subsequent surgery for nodule resection were enrolled in this study. For each patient, color Doppler ultrasonography was performed to observe the variables of the nodules. The nodules were then characterized using the thyroid imaging reporting and data system classification TI-RADS. Furthermore, the ultrasonographic appearance of the control group, encompassing patients with nodular thyroid goiters, and the case group, encompassing patients with papillary thyroid microcarcinoma (PTMC), was statically analyzed. Similarly, a statistical analysis of the ultrasonographic appearance of the BRAF V600E-positive and BRAF V600E-negative subgroups was also performed. The accuracy was significantly different for the corresponding values when color Doppler ultrasonography, BRAF V600E testing, or cytopathology alone was used for diagnosis. There were significant differences in the ultrasonographic appearance variables between the control and case groups. Comparing with the BRAF V600E-negative subgroup of the case group, the ultrasonographic appearances of the BRAF V600E-positive subgroup showed less circumscribed and more irregularly shaped nodules, with significantly different aspect ratios of >1. The combination of BRAF V600E testing and color Doppler ultrasonography or cytopathology improved the accuracy of the PTMC diagnose. We found that the ultrasonographic appearance of thyroid nodules was related to PTMC.

摘要

本研究旨在探讨甲状腺结节的超声表现与BRAF V600E突变之间的相关性。纳入了186例接受BRAF V600E检测和细胞病理学分析并随后接受结节切除手术的甲状腺结节患者。对每位患者进行彩色多普勒超声检查以观察结节的各项变量。然后使用甲状腺影像报告和数据系统分类(TI-RADS)对结节进行特征描述。此外,对包括结节性甲状腺肿患者的对照组和包括甲状腺微小乳头状癌(PTMC)患者的病例组的超声表现进行了统计学分析。同样,也对BRAF V600E阳性和BRAF V600E阴性亚组的超声表现进行了统计学分析。当单独使用彩色多普勒超声、BRAF V600E检测或细胞病理学进行诊断时,相应值的准确性存在显著差异。对照组和病例组之间的超声表现变量存在显著差异。与病例组的BRAF V600E阴性亚组相比,BRAF V600E阳性亚组的超声表现显示结节边界欠清晰且形状更不规则,纵横比>1有显著差异。BRAF V600E检测与彩色多普勒超声或细胞病理学相结合提高了PTMC诊断的准确性。我们发现甲状腺结节的超声表现与PTMC有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cd/8959952/500baa1ff96f/JO2022-5916379.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cd/8959952/500baa1ff96f/JO2022-5916379.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cd/8959952/500baa1ff96f/JO2022-5916379.001.jpg

相似文献

1
Correlation between Ultrasonographic Appearance of Papillary Thyroid Microcarcinoma and BRAF V600E Mutation.甲状腺微小乳头状癌超声表现与BRAF V600E突变的相关性
J Oncol. 2022 Mar 21;2022:5916379. doi: 10.1155/2022/5916379. eCollection 2022.
2
Diagnostic Efficacy of Ultrasound, Cytology, and BRAF Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.超声、细胞学检查及BRAF突变分析在甲状腺微小乳头状癌结节筛查中的诊断效能及其联合应用
Front Oncol. 2022 Jan 3;11:746776. doi: 10.3389/fonc.2021.746776. eCollection 2021.
3
Association Between BRAF Mutation and the American College of Radiology Thyroid Imaging, Reporting and Data System in Solitary Papillary Thyroid Carcinoma.BRAF 突变与孤立性甲状腺乳头状癌的美国放射学会甲状腺影像报告和数据系统之间的关系。
Acad Radiol. 2019 Feb;26(2):154-160. doi: 10.1016/j.acra.2018.05.010. Epub 2018 Jun 23.
4
Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.BRAF V600E、临床病理及影像因素与甲状腺微小乳头状癌复发率的相关性
Exp Ther Med. 2020 Dec;20(6):243. doi: 10.3892/etm.2020.9373. Epub 2020 Oct 22.
5
The Association Among Quantitative Contrast-Enhanced Ultrasonography Features, Thyroid Imaging Reporting and Data System and BRAF V600E Mutation Status in Patients With Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌患者中定量超声造影特征、甲状腺影像报告和数据系统与BRAF V600E突变状态之间的关联
Ultrasound Q. 2019 Sep;35(3):228-232. doi: 10.1097/RUQ.0000000000000406.
6
BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.BRAF V600E 突变与甲状腺细针抽吸细胞学报告的 Bethesda 系统在鉴别甲状腺良恶性结节中的作用。
Medicine (Baltimore). 2021 Sep 17;100(37):e27167. doi: 10.1097/MD.0000000000027167.
7
The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.BRAF(V600E) 突变与甲状腺结节的恶性超声特征相关。
Clin Endocrinol (Oxf). 2011 Dec;75(6):844-50. doi: 10.1111/j.1365-2265.2011.04154.x.
8
[Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].[BRAF(V600E)突变分析及贝塞斯达系统在甲状腺影像报告和数据系统(TIRADS)4类和5类甲状腺结节甲状腺细胞病理学报告中的诊断价值]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Sep 7;52(9):686-691. doi: 10.3760/cma.j.issn.1673-0860.2017.09.010.
9
. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules.TIRADS在预测贝塞斯达系统I、III和V类结节中的甲状腺乳头状癌方面的应用
Cancer Biol Med. 2019 Feb;16(1):131-138. doi: 10.20892/j.issn.2095-3941.2018.0291.
10
[Clinical role of BRAF V600E mutation testing in thyroid nodules].BRAF V600E 突变检测在甲状腺结节中的临床作用
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jun;49(6):468-72.

引用本文的文献

1
Modified TI-RADS Coupled with BRAFV600E Enhances Diagnostic Efficiency in Papillary Thyroid Carcinoma: Prospective Study.改良TI-RADS联合BRAFV600E可提高甲状腺乳头状癌的诊断效率:前瞻性研究
Int J Gen Med. 2024 Jul 10;17:3015-3025. doi: 10.2147/IJGM.S456820. eCollection 2024.
2
Age and Mutation Stratified Patients with Cytologically Benign Thyroid Nodules.年龄和突变分层的细胞学良性甲状腺结节患者。
Int J Gen Med. 2023 Dec 22;16:6025-6039. doi: 10.2147/IJGM.S443711. eCollection 2023.

本文引用的文献

1
Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma.在甲状腺乳头状癌早期,较高的欧盟甲状腺影像报告和数据系统(EU-TIRADS)评分与BRAF V600E阳性相关。
J Clin Med. 2021 May 25;10(11):2304. doi: 10.3390/jcm10112304.
2
Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.BRAF V600E、临床病理及影像因素与甲状腺微小乳头状癌复发率的相关性
Exp Ther Med. 2020 Dec;20(6):243. doi: 10.3892/etm.2020.9373. Epub 2020 Oct 22.
3
Association between BRAF mutation and the clinicopathological features in incidental papillary thyroid microcarcinoma: A single-center study in Turkish patients.
BRAF突变与偶然发现的甲状腺微小乳头状癌临床病理特征之间的关联:一项针对土耳其患者的单中心研究。
North Clin Istanb. 2020 May 28;7(4):321-328. doi: 10.14744/nci.2020.69586. eCollection 2020.
4
Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.成人低危甲状腺微小乳头状癌主动监测的适应证和策略:日本内分泌外科学会甲状腺微小乳头状癌管理工作组的共识声明。
Thyroid. 2021 Feb;31(2):183-192. doi: 10.1089/thy.2020.0330. Epub 2020 Nov 2.
5
BRAF V600E Gene Mutation Is Associated With Bilateral Malignancy of Papillary Thyroid Cancer.BRAF V600E 基因突变与甲状腺乳头状癌双侧恶性肿瘤相关。
Am J Med Sci. 2018 Aug;356(2):130-134. doi: 10.1016/j.amjms.2018.04.012. Epub 2018 Apr 25.
6
Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis.预测中央区颈部高容量淋巴结转移的甲状腺微小乳头状癌的超声特征
Surg Oncol. 2018 Jun;27(2):172-176. doi: 10.1016/j.suronc.2018.03.004. Epub 2018 Mar 27.
7
Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.预测甲状腺微小乳头状癌(CN0)中央区淋巴结转移的风险因素:273 例切除标本的研究。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3801-3807.
8
Ultrasonic features of papillary thyroid microcarcinoma coexisting with a thyroid abnormality.甲状腺微小乳头状癌合并甲状腺异常的超声特征
Oncol Lett. 2016 Oct;12(4):2451-2456. doi: 10.3892/ol.2016.4999. Epub 2016 Aug 11.
9
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making.美国甲状腺协会关于甲状腺结节分子谱分析手术应用的声明:对围手术期决策的当前影响。
Thyroid. 2015 Jul;25(7):760-8. doi: 10.1089/thy.2014.0502. Epub 2015 Jun 24.
10
BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.甲状腺微小乳头状癌中的BRAFV600E突变:一项荟萃分析。
Endocr Relat Cancer. 2015 Apr;22(2):159-68. doi: 10.1530/ERC-14-0531. Epub 2015 Jan 15.